The purpose of this study was to evaluate for differences in variations in pro- and anti-inflammatory cytokine genes between participants who were classified as having low and high levels of morning and evening fatigue and to evaluate for differences in phenotypic characteristics between these two groups. In a sample of 167 oncology outpatients with breast, prostate, lung, or brain cancer and 85 of their family caregivers, growth mixture modeling was used to identify latent classes of individuals based on ratings of morning and evening fatigue obtained prior to, during, and for 4 months following completion of radiation therapy. Differences in single nucleotide polymorphisms and haplotypes in 15 cytokine genes were evaluated between the latent classes. Multiple logistic regression was used to assess the effect of phenotypic and genotypic characteristics on morning and evening fatigue class membership. Associations were found between morning fatigue and number of comorbidities as well as variations in tumor necrosis factor alpha (TNFA) rs1800629 and rs3093662. Evening fatigue was associated with caring for children at home and variations in interleukin 4 (IL4) rs2243248 and TNFA rs2229094. Younger age and lower performance status were associated with both morning and evening fatigue. These findings suggest that inflammatory mediators are associated with the development of morning and evening fatigue. However, because different phenotypic characteristics and genomic markers are associated with diurnal variations in fatigue, morning and evening fatigue may be distinct but related symptoms.
AouizeratB. E.DoddM.LeeK.WestC.PaulS. M.CooperB. A.…MiaskowskiC. (2009). Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biological Research for Nursing, 11, 27–41. doi: 10.1177/ 1099800409333871
2.
AtkinsM. B.VachinoG.TilgH. J.KarpD. D.RobertN. J.KapplerK.MierJ. W. (1992). Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy. Journal of Clinical Oncology, 10, 1802–1809.
3.
BarsevickA.FrostM.ZwindermanA.HallP.HalyardM. (2010). I'm so tired: Biological and genetic mechanisms of cancer-related fatigue. Quality of Life Research, 19, 1419–1427. doi:10.1007/s11136-010-9757-7
4.
BiedermannT.RockenM. (2005). Pro- and anti-inflammatory effects of IL-4: From studies in mice to therapy of autoimmune diseases in humans. Ernst Schering Research Foundation Workshop, 50, 235–242.
5.
BishehsariF.SharmaA.StelloK.TothC.O'ConnellM. R.EvansA. C.…WhitcombD. C. (2012). TNF-alpha gene (TNFA) variants increase risk for multi-organ dysfunction syndrome (MODS) in acute pancreatitis. Pancreatology, 12, 113–118. doi:10.1016/j.pan.2012.02.014
6.
BowerJ. E.GanzP. A.IrwinM. R.ArevaloJ. M.ColeS. W. (2011). Fatigue and gene expression in human leukocytes: Increased NF-kappaB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain, Behavior, and Immunity, 25, 147–150.
7.
BowerJ. E.GanzP. A.IrwinM. R.KwanL.BreenE. C.ColeS. W. (2011). Inflammation and behavioral symptoms after breast cancer treatment: Do fatigue, depression, and sleep disturbance share a common underlying mechanism?Journal of Clinical Oncology, 29, 3517–3522. doi:10.1200/JCO.2011.36.1154
8.
BowerJ. E.GanzP. A.TaoM. L.HuW.BelinT. R.SepahS.…AzizN. (2009). Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clinical Cancer Research, 15, 5534–5540.
9.
BrennerA. V.ButlerM. A.WangS. S.RuderA. M.RothmanN.SchulteP. A.…InskipP. D. (2007). Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis, 28, 2543–2547. doi:10.1093/carcin/bgm210
10.
BrownE. E.FallinM. D.GoedertJ. J.HutchinsonA.VitaleF.LauriaC.…ChanockS. J. (2006). Host immunogenetics and control of human herpesvirus-8 infection. Journal of Infectious Diseases, 193, 1054–1062.
11.
CarneyS.KoettersT.ChoM.WestC.PaulS. M.DunnL.…MiaskowskiC. (2011). Differences in sleep disturbance parameters between oncology outpatients and their family caregivers. Journal of Clinical Oncology, 29, 1001–1006.
12.
CerriA. P.ArosioB.ViazzoliC.ConfalonieriR.TeruzziF.AnnoniG. (2009). -308(G/A) TNF-alpha gene polymorphism and risk of depression late in the life. Archives of Gerontology and Geriatrics, 49, 29–34.
13.
Collado-HidalgoA.BowerJ. E.GanzP. A.IrwinM. R.ColeS. W. (2008). Cytokine gene polymorphisms and fatigue in breast cancer survivors: Early findings. Brain Behavior and Immunity, 22, 1197–1200. doi: 10.1016/j.bbi.2008.05.009
14.
CondeL.VaquerizasJ. M.DopazoH.ArbizaL.ReumersJ.RousseauF.…DopazoJ. (2006). PupaSuite: Finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Research, 34, W621–W625.
15.
DantzerR.CapuronL.IrwinM. R.MillerA. H.OllatH.PerryV. H.…YirmiyaR. (2008). Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology, 33, 18–29.
16.
DhruvaA.AouizeratB. E.CooperB.PaulS. M.DoddM.WestC.…MiaskowskiC. (2013). Differences in morning and evening fatigue in oncology patients and their family caregivers. European Journal of Oncology Nursing, 16, 841–848.
17.
DhruvaA.LeeK.PaulS. M.WestC.DunnL.DoddM.…MiaskowskiC. (2012). Sleep-wake circadian activity rhythms and fatigue in family caregivers of oncology patients. Cancer Nursing, 35, 70–81. doi:10.1097/NCC.0b013e3182194a25
18.
DunnL. B.AouizeratB. E.CooperB. A.DoddM.LeeK.WestC.…MiaskowskiC. (2012). Trajectories of anxiety in oncology patients and family caregivers during and after radiation therapy. European Journal of Oncology Nursing, 16, 1–9. doi: 10.1016/j.ejon.2011.01.003
19.
Encode Project Consortium, DunhamI.KundajeA.AldredS. F.CollinsP. J.DavisC. A.BirneyE. (2012). An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57–74. doi:10.1038/nature11247
20.
ErdeiE.KangH.MeisnerA.WhiteK.PickettG.BacaC.…BerwickM. (2010). Polymorphisms in cytokine genes and serum cytokine levels among New Mexican women with and without breast cancer. Cytokine, 51, 18–24. doi:10.1016/j.cyto.2010.03.014
21.
GabrielS. B.SchaffnerS. F.NguyenH.MooreJ. M.RoyJ.BlumenstielB.…AltshulerD. (2002). The structure of haplotype blocks in the human genome. Science, 296, 2225–2229. doi:10.1126/science.1069424
22.
GallicchioL.ChangH.ChristoD. K.ThuitaL.HuangH. Y.StricklandP.…HelzlsouerK. J. (2008). Single nucleotide polymorphisms in inflammation-related genes and mortality in a community-based cohort in Washington County, Maryland. American Journal of Epidemiology, 167, 807–813. doi:10.1093/aje/kwm378
23.
Gilbertson-WhiteS.AouizeratB. E.MiaskowskiC. (2011). Methodologic issues in the measurement of cytokines to elucidate the biological basis for cancer symptoms. Biological Research for Nursing, 13, 15–24. doi:10.1177/1099800410379497
24.
GilleeceM. H.ScarffeJ. H.GhoshA.HeyworthC. M.BonnemE.TestaN.…DexterT. M. (1992). Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections—A phase I dose toxicity trial. British Journal of Cancer, 66, 204–210.
25.
HalderI.ShriverM.ThomasM.FernandezJ. R.FrudakisT. (2008). A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: Utility and applications. Human Mutation, 29, 648–658.
26.
HattersleyA. T.McCarthyM. I. (2005). What makes a good genetic association study?Lancet, 366, 1315–1323.
27.
HenryD. H.ViswanathanH. N.ElkinE. P.TrainaS.WadeS.CellaD. (2008). Symptoms and treatment burden associated with cancer treatment: Results from a cross-sectional national survey in the U.S. Supportive Care in Cancer, 16, 791–801. doi:10.1007/s00520-007-0380-2
28.
HofmanM.RyanJ. L.Figueroa-MoseleyC. D.Jean-PierreP.MorrowG. R. (2007). Cancer-related fatigue: The scale of the problem. Oncologist, 12, 4–10.
29.
HoggartC. J.ParraE. J.ShriverM. D.BonillaC.KittlesR. A.ClaytonD. G.McKeigueP. M. (2003). Control of confounding of genetic associations in stratified populations. American Journal of Human Genetics, 72, 1492–1504.
30.
HongJ. H.ChiangC. S.CampbellI. L.SunJ. R.WithersH. R.McBrideW. H. (1995). Induction of acute phase gene expression by brain irradiation. International Journal of Radiation Oncology Biology Physics, 33, 619–626.
31.
IlliJ.MiaskowskiC.CooperB.LevineJ. D.DunnL.WestC.…AouizeratB. E. (2012). Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression. Cytokine, 58, 437–447. doi:10.1016/j.cyto.2012.02.015
32.
IsraniA. K.LiN.CizmanB. B.SnyderJ.AbramsJ.JoffeM.…FeldmanH. I. (2008). Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation. American Journal of Kidney Disease, 52, 331–339. doi:10.1053/j.ajkd.2008.05.006
33.
JagerA.SleijferS.van der RijtC. C. (2008). The pathogenesis of cancer related fatigue: Could increased activity of pro-inflammatory cytokines be the common denominator?European Journal of Cancer, 44, 175–181. doi: 10.1016/j.ejca.2007.11.023
34.
JeanmonodP.von KanelR.MalyF. E.FischerJ. E. (2004). Elevated plasma C-reactive protein in chronically distressed subjects who carry the A allele of the TNF-alpha-308 G/A polymorphism. Psychosomatic Medicine, 66, 501–506. doi:10.1097/01.psy.0000130903.78444.7d
35.
KroegerK. M.CarvilleK. S.AbrahamL. J. (1997). The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Molecular Immunology, 34, 391–399.
36.
KroegerK. M.SteerJ. H.JoyceD. A.AbrahamL. J. (2000). Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine, 12, 110–119. doi:10.1006/cyto.1999.0529
37.
LawrenceD. P.KupelnickB.MillerK.DevineD.LauJ. (2004). Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. Journal of the National Cancer Institute, 32, 40–50.
38.
LeeK. A.HicksG.Nino-MurciaG. (1991). Validity and reliability of a scale to assess fatigue. Psychiatry Research, 36, 291–298.
39.
LeeY. H.WooJ. H.RhoY. H.ChoiS. J.JiJ. D.SongG. G. (2008). Meta-analysis of the combination of TNF inhibitors plus MTX compared to MTX monotherapy, and the adjusted indirect comparison of TNF inhibitors in patients suffering from active rheumatoid arthritis. Rheumatology International, 28, 553–559. doi:10.1007/s00296-007-0475-6
40.
LeungL.CahillC. M. (2010). TNF-alpha and neuropathic pain—A review. Journal of Neuroinflammation, 7, 27.
41.
LiD.LewingerJ. P.GaudermanW. J.MurcrayC. E.ContiD. (2011). Using extreme phenotype sampling to identify the rare causal variants of quantitative traits in association studies. Genetic Epidemiology, 35, 790–799. doi:10.1002/gepi.20628
42.
LiuL.MillsP. J.RisslingM.FiorentinoL.NatarajanL.DimsdaleJ. E.…Ancoli-IsraelS. (2012). Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain, Behavior, and Immunity, 26, 706–713. doi:10.1016/j.bbi.2012.02.001
43.
LiuY.ShengH.LuL.WuZ.ChenQ.XiaoH.JinW. (2011). Haplotype-based association of four lymphotoxin-alpha gene polymorphisms with the risk of coronary artery disease in Han Chinese. Tohoku Journal of Experimental Medicine, 224, 119–125.
44.
MahajanA.TabassumR.ChavaliS.DwivediO. P.ChauhanG.TandonN.BharadwajD. (2010). Obesity-dependent association of TNF-LTA locus with type 2 diabetes in North Indians. Journal of Molecular Medicine, 88, 515–522. doi:10.1007/s00109-010-0594-5
45.
MajhailN. S.HusseinM.OlenckiT. E.BuddG. T.WoodL.ElsonP.BukowskiR. M. (2004). Phase I trial of continuous infusion recombinant human interleukin-4 in patients with cancer. Investigational New Drugs, 22, 421–426. doi:10.1023/B: DRUG.0000036684.67675.fe
46.
McCannB.MiaskowskiC.KoettersT.BaggottC.WestC.LevineJ. D.…AouizeratB. E. (2012). Associations between pro- and anti-inflammatory cytokine genes and breast pain in women prior to breast cancer surgery. Journal of Pain, 13, 425–437. doi:10.1016/j.jpain.2011.02.358
47.
MiaskowskiC.CooperB. A.DhruvaA.DunnL. B.LangfordD. J.CataldoJ. K.…AouizeratB. E. (2012). Evidence of associations between cytokine genes and subjective reports of sleep disturbance in oncology patients and their family caregivers. PLoS One. 7, e40560. doi:10.1371/journal.pone0040560
48.
MiaskowskiC.DoddM.LeeK.WestC.PaulS. M.CooperB. A.…AouizeratB. E. (2010). Preliminary evidence of an association between a functional interleukin-6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers. Journal of Pain and Symptom Management, 40, 531–544.
49.
MiaskowskiC.LeeK.DunnL.DoddM.AouizeratB. E.WestC.…SwiftP. (2011). Sleep-wake circadian activity rhythm parameters and fatigue in oncology patients before the initiation of radiation therapy. Cancer Nursing, 34, 255–268. doi:10.1097/NCC.0b013e3181f65d9b
50.
MuthenB. O.KaplanD. W. (2004). Latent variable analysis: Growth mixture modeling and related techniques for longitudinal data. In KaplanD. (Ed.), The Sage handbook of quantitative methodology for the social sciences (pp. 345–368). Newbury Park, CA: Sage.
51.
MuthenL. K.MuthenB. O. (1998–2010). Mplus user's guide (6th ed.). Los Angeles, CA: Author.
52.
MyersJ. S. (2008). Proinflammatory cytokines and sickness behavior: Implications for depression and cancer-related symptoms. Oncology Nursing Forum, 35, 802–807.
53.
OikariL. E.StuartS.OkolicsanyiR. K.CoxH. C.DixitS.LeaR. A.…GriffithsL. R. (2013). Investigation of lymphotoxin alpha genetic variants in migraine. Gene, 512, 527–531. doi:10.1016/j.gene.2012.09.116
54.
PriceA. L.PattersonN. J.PlengeR. M.WeinblattM. E.ShadickN. A.ReichD. (2006). Principal components analysis corrects for stratification in genome-wide association studies. Nature Genetics, 38, 904–909.
55.
RaisonC. L.RutherfordR. E.WoolwineB. J.ShuoC.SchettlerP.DrakeD. F.…MillerA. H. (2013). A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers. JAMA Psychiatry, 70, 31–41. doi:10.1001/2013.jamapsychiatry.4
56.
ReinertsenK. V.Grenaker AlnaesG. I.Landmark-HoyvikH.LogeJ. H.WistE.KristensenV. N.…EdvardsenH. (2011). Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway. Brain, Behavior, and Immunity, 25, 1376–1383. doi:10.1016/j.bbi.2011.04.001
RojasJ.FernandezI.PastorJ. C.Garcia-GutierrezM. T.SanabriaM. R.BrionM.…CarracedoA. (2010). A strong genetic association between the tumor necrosis factor locus and proliferative vitreoretinopathy: The retina 4 project. Ophthalmology, 117, 2417–2423.e2. doi:10.1016/j.ophtha.2010.03.059
59.
RothmanK. J. (1990). No adjustments are needed for multiple comparisons. Epidemiology, 1, 43–46.
60.
SchubertC.HongS.NatarajanL.MillsP. J.DimsdaleJ. E. (2007). The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review. Brain, Behavior, and Immunity, 21, 413–427. doi:10.1016/j.bbi.2006.11.004
61.
SerugaB.ZhangH.BernsteinL. J.TannockI. F. (2008). Cytokines and their relationship to the symptoms and outcome of cancer. Nature Reviews Cancer, 8, 887–899.
62.
SPSS. (2010). IBM SPSS for Windows(Version 19). Chicago, IL: Author.
63.
StephensM.SmithN. J.DonnellyP. (2001). A new statistical method for haplotype reconstruction from population data. American Journal of Human Genetics, 68, 978–989.
64.
Swore FletcherB. A.DoddM. J.SchumacherK. L.MiaskowskiC. (2008). Symptom experience of family caregivers of patients with cancer. Oncology Nursing Forum, 35, E23–E44.
65.
TakeiK.IkedaS.AraiT.TanakaN.MuramatsuM.SawabeM. (2008). Lymphotoxin-alpha polymorphisms and presence of cancer in 1,536 consecutive autopsy cases. BMC Cancer, 8, 235. doi:10.1186/1471-2407-8-235
66.
TaylorC. W.LeBlancM.FisherR. I.MooreD. F.SrRoachR. W.EliasL.MillerT. P. (2000). Phase II evaluation of interleukin-4 in patients with non-Hodgkin's lymphoma: A Southwest Oncology Group trial. Anticancer Drugs, 11, 695–700.
67.
TianC.GregersenP. K.SeldinM. F. (2008). Accounting for ancestry: Population substructure and genome-wide association studies. Human Molecular Genetics, 17, R143–R150.
68.
VokesE. E.FiglinR.HochsterH.LotzeM.RybakM. E. (1998). A phase II study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancer. Cancer Journal from Scientific American, 4, 46–51.
69.
WangX. S.ShiQ.WilliamsL. A.MaoL.CleelandC. S.KomakiR. R.…LiaoZ. (2010). Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain, Behavior, and Immunity, 24, 968–974.
70.
WhiteheadR. P.LewD.FlaniganR. C.WeissG. R.RoyV.GlodeM. L.…CrawfordE. D. (2002). Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: A Southwest Oncology Group study. Journal of Immunotherapy, 25, 352–358.
71.
WhiteheadR. P.UngerJ. M.GoodwinJ. W.WalkerM. J.ThompsonJ. A.FlahertyL. E.SondakV. K. (1998). Phase II trial of recombinant human interleukin-4 in patients with disseminated malignant melanoma: A Southwest Oncology Group study. Journal of Immunotherapy, 21, 440–446.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
